Menichella Daniel L 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Sep 1, 2010
Insider Transaction Report
Form 4
Menichella Daniel L
Sr. VP, Business Development
Transactions
- Sale
Common Stock
2010-08-30$22.05/sh−100,000$2,204,830→ 17,013 total
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2010.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.98 to $22.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes a grant by the Issuer to the Reporting Person of 5,921 options to purchase the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.